ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany

Ostermann H, Bruno B, Greiner W, Possinger K, Tesch H, Zaun S, Maass N (2011)
Onkologie 34: 61-62.

Download
No fulltext has been uploaded. References only!
Conference Abstract | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Ostermann H, Bruno B, Greiner W, et al. ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie. 2011;34:61-62.
Ostermann, H., Bruno, B., Greiner, W., Possinger, K., Tesch, H., Zaun, S., & Maass, N. (2011). ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie, 34, 61-62.
Ostermann, H., Bruno, B., Greiner, W., Possinger, K., Tesch, H., Zaun, S., and Maass, N. (2011). ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie 34, 61-62.
Ostermann, H., et al., 2011. ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie, 34, p 61-62.
H. Ostermann, et al., “ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany”, Onkologie, vol. 34, 2011, pp. 61-62.
Ostermann, H., Bruno, B., Greiner, W., Possinger, K., Tesch, H., Zaun, S., Maass, N.: ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany. Onkologie. 34, 61-62 (2011).
Ostermann, H., Bruno, B., Greiner, Wolfgang, Possinger, K., Tesch, H., Zaun, S., and Maass, N. “ACT-FASTER: An epidemiological prospective Cohort Study to describe treatment patterns of fulvestrant and exemestane in postmenopausal patients with advanced HR+ breast cancer under real-life conditions in Germany”. Onkologie 34 (2011): 61-62.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar